NCT06938906 Multimodal Therapy Impact on Pancreatic Cancer Survival Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06938282 An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06937112 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis Status RECRUITING Phase N/A
NCT06920082 Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT06898385 A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation Status RECRUITING Phase PHASE1
NCT06893276 e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients Status NOT_YET_RECRUITING Phase NA
NCT06885424 A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products Status ENROLLING_BY_INVITATION Phase N/A
NCT06873178 The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06872489 Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors Status AVAILABLE Phase N/A
NCT06866977 A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06849063 Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE Status RECRUITING Phase N/A
NCT06844422 Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) Status RECRUITING Phase PHASE1/PHASE2
NCT06843629 Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors Status RECRUITING Phase N/A
NCT06821048 Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06819215 Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2